{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:07Z","timestamp":1792431967766,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Uterine leiomyosarcoma (uLMS) is a rare and aggressive cancer with few effective therapeutics. The Notch signaling pathway is evolutionarily conserved with oncogenic properties, but it has not been well studied in uLMS. The purpose of our study was to determine expression of Notch family genes and proteins and to investigate the therapeutic effect of \u03b3-secretase inhibitors (GSIs), indirect inhibitors of Notch signaling, in uLMS. We determined expression of Notch genes and proteins in benign uterine smooth muscle tissue, fibroids, and uLMS samples by immunostaining and in two uLMS cell lines, SK-UT-1B (uterine primary) and SK-LMS-1 (vulvar metastasis) by RT-PCR, Western blot and immunostaining. We exposed our cell lines to GSIs, DAPT and MK-0752, and measured expression of HES1, a downstream effector of Notch. Notch proteins were differentially expressed in uLMS. Expression of NOTCH3 and NOTCH4 was higher in uLMS samples than in benign uterine smooth muscle and fibroids. Expression of NOTCH4 was higher in SK-LMS-1 compared to SK-UT-1B. Exposure of SK-UT-1B and SK-LMS-1 to DAPT and MK-0752 decreased expression of HES1 and decreased uLMS cell viability in a dose- and time-dependent manner that was unique to each GSI. Our findings suggest that GSIs are potential therapeutics for uLMS, albeit with limited efficacy.<\/jats:p>","DOI":"10.3390\/ijms23115980","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:50:22Z","timestamp":1653555022000},"page":"5980","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-1919","authenticated-orcid":false,"given":"Yasmin","family":"Abedin","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Gabrilovich","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-1389","authenticated-orcid":false,"given":"Emily","family":"Alpert","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5702","authenticated-orcid":false,"given":"Erica","family":"Rego","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Begum","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Heller","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"},{"name":"Department of Pathology, Immunology and Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataki C.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Health, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.12998\/wjcc.v7.i14.1753","article-title":"Current status of the adjuvant therapy in uterine sarcoma: A literature review","volume":"7","author":"Rizzo","year":"2019","journal-title":"World J. Clin. Cases"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: A review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0090-8258(03)00137-9","article-title":"Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy","volume":"89","author":"Giuntoli","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygyno.2017.02.012","article-title":"Prognosis and treatment of uterine leiomyosarcoma: A national cancer database study","volume":"145","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Nannini, M., Astolfi, A., Indio, V., de Iaco, P., Perrone, A.M., de Leo, A., Incorvaia, L., Di Scioscio, V., and Pantaleo, M.A. (2020). Impact of chemotherapy in the adjuvant setting of early stage uterine leiomyosarcoma: A systematic review and updated meta-analysis. Cancers, 12.","DOI":"10.3390\/cancers12071899"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Astolfi, A., Nannini, M., Indio, V., Schipani, A., Rizzo, A., Perrone, A.M., de Iaco, P., Pirini, M.G., de Leo, A., and Urbini, M. (2020). Genomic database analysis of uterine leiomyosarcoma mutational profile. Cancers, 12.","DOI":"10.3390\/cancers12082126"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejca.2008.01.019","article-title":"Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European organisation for research and treatment of cancer gynaecological cancer group study (protocol 55874)","volume":"44","author":"Reed","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E","article-title":"A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas","volume":"52","author":"Omura","year":"1983","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial","volume":"20","author":"Hensley","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","article-title":"Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A gynecologic oncology group phase II trial","volume":"109","author":"Hensley","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/243298","article-title":"Potential therapeutic targets in uterine sarcomas","volume":"2015","author":"Cuppens","year":"2015","journal-title":"Sarcoma"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Garcia, N., Al-Hendy, A., Baracat, E.C., Carvalho, K.C., and Yang, Q. (2020). Targeting hedgehog pathway and DNA methyltransferases in uterine leiomyosarcoma cells. Cells, 10.","DOI":"10.21203\/rs.3.rs-27677\/v1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1084\/jem.20111855","article-title":"Oncogenic and tumor suppressor functions of Notch in cancer: It\u2019s NOTCH what you think","volume":"208","author":"Lobry","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Moore, G., Annett, S., McClements, L., and Robson, T. (2020). Top notch targeting strategies in cancer: A detailed overview of recent insights and current perspectives. Cells, 9.","DOI":"10.3390\/cells9061503"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.medici.2014.05.002","article-title":"NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer","volume":"50","year":"2014","journal-title":"Medicina"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2015.11.021","article-title":"A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer","volume":"56","author":"Pant","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/annonc\/mdy244","article-title":"First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer","volume":"29","author":"Massard","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1469-7580.2008.00963.x","article-title":"The pattern of expression of Notch protein members in normal and pathological endometrium","volume":"213","author":"Cobellis","year":"2008","journal-title":"J. Anat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2559.2011.04158.x","article-title":"Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells","volume":"60","author":"Mitsuhashi","year":"2012","journal-title":"Histopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canlet.2015.07.048","article-title":"Notch signaling: An emerging therapeutic target for cancer treatment","volume":"369","author":"Yuan","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fncel.2014.00427","article-title":"The \u03b3-secretase complex: From structure to function","volume":"8","author":"Zhang","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1074\/jbc.M513012200","article-title":"C-terminal fragment of presenilin is the molecular target of a dipeptidic gamma-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester)","volume":"281","author":"Morohashi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1021\/bi200026m","article-title":"Identification of presenilin 1-selective \u03b3-secretase inhibitors with reconstituted \u03b3-secretase complexes","volume":"50","author":"Lee","year":"2011","journal-title":"Biochemistry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2015.12.011","article-title":"Sequential combination therapy of ovarian cancer with cisplatin and \u03b3-secretase inhibitor MK-0752","volume":"140","author":"Chen","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00381-015-2725-3","article-title":"Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: A pediatric brain tumor consortium study","volume":"31","author":"Hoffman","year":"2015","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bjc.2017.495","article-title":"A phase I trial of the \u03b3-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma","volume":"118","author":"Cook","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","article-title":"Berberine regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells","volume":"59","author":"Li","year":"2021","journal-title":"Pharm. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7538649","DOI":"10.1155\/2022\/7538649","article-title":"Impact of Notch3 activation on aortic aneurysm development in marfan syndrome","volume":"2022","author":"Jespersen","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.2003.tb03219.x","article-title":"Notch signaling in primary endothelial cells","volume":"995","author":"Shawber","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41467-019-09470-w","article-title":"A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma","volume":"10","author":"Akogul","year":"2019","journal-title":"Nat Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12958-015-0084-2","article-title":"Aberrant expression of Notch1\/numb\/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis","volume":"13","author":"Qi","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"gaab053","DOI":"10.1093\/molehr\/gaab053","article-title":"Immune cells and Notch1 signaling appear to drive the epithelial to mesenchymal transition in the development of adenomyosis in mice","volume":"27","author":"Bourdon","year":"2021","journal-title":"Mol. Hum. Reprod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13221-015-0034-y","article-title":"Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus","volume":"7","author":"Shawber","year":"2015","journal-title":"Vasc. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/1947601911423030","article-title":"Notch signaling in developmental and tumor angiogenesis","volume":"2","author":"Kofler","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/REP-20-0483","article-title":"Implications for preeclampsia: Hypoxia-induced Notch promotes trophoblast migration","volume":"161","author":"Perlman","year":"2021","journal-title":"Reproduction"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/1078-0432.CCR-11-3326","article-title":"Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors","volume":"19","author":"Schott","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2013.01.054","article-title":"Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer","volume":"335","author":"Yabuuchi","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2018.08.012","article-title":"Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours","volume":"103","author":"Mir","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1541-7786.MCR-20-0197","article-title":"Oncogenic gene-expression programs in leiomyosarcoma and characterization of conventional, inflammatory, and uterogenic subtypes","volume":"18","author":"Hemming","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ygyno.2017.06.005","article-title":"Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models","volume":"146","author":"Cuppens","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue\u2013A review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn. Pathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/5980\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:00Z","timestamp":1760138340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/5980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23115980"],"URL":"https:\/\/doi.org\/10.3390\/ijms23115980","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}